Literature DB >> 34002553

Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization.

Hyeon Jeong Suh1,2, Eunyoung Lee2, Sang Won Park3.   

Abstract

BACKGROUND: Some coronavirus disease 2019 (COVID-19) patients initially present with early oxygen demand, requiring more medical resources, and some develop severe conditions, while others worsen later in their clinical course. Whether the nature of the two groups is the same but in the spectrum of different diagnostic time points is not certain.
METHODS: Hospitalized COVID-19 patients who needed oxygen therapy from February to November 2020 were included in the study. The patients were divided into early and late groups based on the time when the oxygen requirement occurred. Basic and epidemiologic characteristics were compared. Clinical variables were analyzed in both groups.
RESULTS: A total of 164 patients needed oxygen therapy, 94 of whom were in the early group and 70 of whom were in the late group. The early and late groups had similar baseline characteristics except age (median age, 73 vs. 67 years), uncertain exposure history (50% vs. 31.4%) and the time from the onset of illness to admission (median, 5 vs. 2 days). Multivariate analysis showed that age > 65 years (OR, 4.65), symptom onset > 5 days (OR, 9.13) and several clinical manifestations, such as febrile sensation (OR, 6.01), dyspnea (OR, 30.0), C-reactive protein > 1 mg/dL (OR, 7.87) and chest X-ray abnormality (OR, 8.15), were predictive factors in the early group. The early group required more intensive care such as mechanical ventilation care, extracorporeal membrane oxygenation and death (29.8% vs. 14.3%, P = 0.002).
CONCLUSION: Older age, especially > 65 years, and a delay of over 5 days from the onset of illness to admission were associated with early oxygen demand in COVID-19 patients. Interventions for earlier diagnosis of elderly people may benefit clinical outcomes.
© 2021 The Korean Academy of Medical Sciences.

Entities:  

Keywords:  Aged; COVID-19; Early Diagnosis; Hypoxemia; SARS-CoV-2

Year:  2021        PMID: 34002553     DOI: 10.3346/jkms.2021.36.e139

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  2 in total

1.  Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease.

Authors:  Ji Yeon Lee; Jee Young Lee; Jae-Hoon Ko; Miri Hyun; Hyun Ah Kim; Seongcheol Cho; Yong Dae Lee; Junghoon Song; Seunghwan Shin; Kyong Ran Peck
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

2.  Clinical Characteristics and Risk Factors for Severe Disease of Coronavirus Disease 2019 in a Low Case Fatality Rate Region in Korea.

Authors:  Sang Taek Heo; Hyunjoo Oh; Misun Kim; Jeong Rae Yoo; Hyang Ran Lee
Journal:  Infect Chemother       Date:  2021-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.